Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-01-06 @ 4:50 PM
Study NCT ID:
NCT03411850
Status:
UNKNOWN
Last Update Posted:
2021-05-11
First Post:
2016-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sjogrens Syndrome Measured by Ultrasound
Sponsor:
Arthritis & Rheumatism Associates, P.C.
Organization:
Study Overview
Official Title:
Disease Modification in Sjogrens Syndrome Measured by Ultrasound: A Pilot Study
Status:
UNKNOWN
Status Verified Date:
2021-05
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ultrasound study focused on salivary gland outcomes in Sjogren's subjects
Detailed Description:
A 32 week ultrasound study for subject diagnosed with Sjogren's Syndrome. Subjects will receive Orencia (Abatacept) as intervention therapy during this trial.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: